Learn How to Build Your Glutes with Cable Kickbacks

Before I tell you how to build powerful glutes with cable kickbacks, I will discuss the importance of training them in the first place. Generally, people will think that training glutes is a feminine thing. But men should train too. Women will often train their glutes to look good.  On the other hand, men should consider this exercise since a man’s “butt” is one of the physical features that women notice first.

Glutes offer a perfect base of power for most athletic movements. They are also accountable for hip extension. Powerful hips mean that you can jump higher, run faster, and tackle harder.

The Advantages of Cable Kickbacks

Before you decide to begin doing cable kickbacks, you might want to know their advantages first.

Here they are:

  • Glute isolation: you might have heard the term “mind-muscle connection” being used by bodybuilders. This is the notion that focusing on feeling a target muscle working its range of motion will enable you to activate it more. More muscle activation leads to increased growth. This mind-muscle connection can be used to activate your biceps. But the same cannot be said for glutes. This is where cable kickbacks come in. When performing a cable kickback, you isolate your glutes through hip extension. You can focus on one side at a time and you will feel the glutes stretching and contracting.
  • Similar to real-life movement: people will often train around exercises that work a specific muscle but which has little transfer to their daily life. Cable kickbacks do this by mimicking the movements you use when running and walking. This exercise will work out your glutes the same way they will be used each day when walking or running.
  • Offers constant tension on your glutes: cable kickbacks, unlike bars and dumbbells, provide constant tension to your glutes during the movement. There is no resting point since the cable is always pulling against you. The constant tension makes exercise tougher hence the target muscles work harder for longer. The duration spent under tension is the key driver for muscle hypertrophy.

 

 

 

How to Carry Out Glute Cable Kickbacks

Cable kickbacks can be done when standing or when kneeling. Kneeling provides a wider range of motion, which is helpful. However, it is easy to feel the peak contraction while standing. Additionally, it is easy to keep a neutral lumbar spine with standing kickbacks.

The Standing Cable Kickback Technique

Source: bodybuilding.com

  1. Attach an ankle strap to a cable machine.
  2. Move the pulley to the bottom of the machine.
  3. Face the stack of weights and take a step back to make the weights to lift a bit. This creates tension from the very beginning of the movement.
  4. Use the machine for support but make sure that your abs are braced and your spine is in neutral alignment.
  5. From the starting position, push the heel of the attached ankle behind you to extend your hip. Keep your knee straight and push your leg behind you until you feel your glute muscles contract.
  6. Remain in that position for two seconds then return to the start position slowly.

The kneeling cable kickback technique

 

ca

Source: Vegan Bikini Doc

  1. Place a flat bench in front of a cable machine
  2. Attach an ankle cuff to the machine and lower the pulley to the bottom.
  3. Facing the cable stack, kneel on the bench with one leg and attach the other to the ankle cuff.
  4. Swing the attached leg towards machine.
  5. Push back your leg behind you until your hip is completely extended.
  6. Hold this position for one to two seconds.
  7. Move back to your original position and repeat.

 

 

Tips on Cable Kickbacks

There are several key points that will help you get the most out of cable kickbacks.

  • Keep your back straight and neutral: it is very important to keep back neutral straight. This ensures that tension is applied on your glutes and not your lower back. As a result, you will get better glute activation and you will not injure your back.
  • Keep in spine in alignment: to do this, keep your abs tensed during the exercise. Before each rep, make sure that your abs are braced.
  • Do not overextend your lower back: as you push your leg back to extend your hips, ensure that you do not overextend your lower back as this could hurt it.
  • Contract your glutes and pause at the end of the rep: this ensures that you activate your glutes even more.

Lastly…..

Try out the two cable kickback techniques and put more energy into the one that feels great for you. Including cable kickbacks in your routine is a great step towards activating your glutes. You can also perform big compound exercises such as squats and deadlifts.

Let me know if this guide helps you. Enjoy your cable kickbacks!

About Me

My name is Daniel and I am fitness trainer based in Toronto. I work with people of all ages to help them reach their fitness goals from their homes. You can contact me The Fitness Crab in order for me to help you set up your home gym, recommend what equipment you should buy such as exercise bikes, treadmills and rowers as well as prepare work out and nutrition plans that best suit you.

 

 

 

 

Hyperloop, smart homes, a personal helicopter, wearable technology, healthtech and cleantech among the many head-turning innovations at Discovery 2017

TORONTO, May 9, 2017 /CNW/ - Ontario Centres of Excellence's (OCE's) award-winning Discovery conference returns to the Metro Toronto Convention Centre, South Building on May 15-16. The hotly anticipated annual event is celebrating 12 years of bold, new ideas with a dynamic showcase of the best Ontario and Canadian innovators have to offer.

Discovery's 200,000-square-foot show floor is packed with made-in-Ontario exhibits, exciting and informative panels and interactive sessions. Featured this year among the more than 500 exhibits are some of the latest developments in next-generation transportation including a Hyperloop Zone with virtual reality simulations and a levitation pod from Waterloop, smart cars from Tesla and General Motors featuring AI integration, an ultramodern smart home, a cutting-edge aerospace zone with a personal helicopter prototype from Airvinci, robotics, healthtech, biometrics, wearable tech including biosensor clothing, and augmented reality demonstrations.

"Over the past decade OCE's Discovery has brought some of the most exciting speakers, entrepreneurs and global thought leaders from Ontario and around the globe to our two-day celebration of the innovation ecosystem," says Dr. Tom Corr, President and CEO of OCE. "Discovery brings together industry, academia, investors, government, students, young entrepreneurs and more to share ideas, network, invest and create business relationships that drive Ontario's economic growth and global competitiveness."

"Our government recognizes that innovations like the ones unveiled at OCE Discovery create the jobs and technologies that will fuel our economy now and in the future," says Brad Duguid, Minister of Economic Development and Growth. "We are pleased to support these next-generation ideas that will boost Ontario's competitive advantage in a fierce and fast-changing global economy and maintain our position at the leading edge of technological innovation."

Named Canada's Best Trade Show in 2010, 2011, and 2016, OCE's Discovery is Canada's premier innovation showcase. It brings together the best and brightest minds in industry, academia, investment and government to showcase leading-edge technologies, best practices and research in the areas of energy, fintech, cleantech, advanced health, digital media, information and communication technologies and advanced manufacturing. The annual conference and trade show attracts more than 3,500 attendees and 500 exhibitors.

"Discovery is a showcase for the kind of game-changing technologies that improve our lives and drive Ontario's knowledge-based economy," says Reza Moridi, Minister of Research, Innovation and Science. "As part of our government's Ontario Network of Entrepreneurs, we are proud to support OCE Discovery in advancing these cutting-edge collaborations at every stage of their development."

Discovery will feature two main-stage keynote speakers:

On May 15, Jared Cohen, founder of Google Ideas and President of Jigsaw will speaking from the main stage about the new digital age from his unique vantage point at the centre of technology and how it is changing the world, especially for the 5 billion people expected to come online in the next decade.

On May 16, Gina McCarthy will deliver an environmental message on both the mainstage and in the Discovery Theatre that conveys common sense strategies and sustainable solutions backed by science. McCarthy is well-known and celebrated for her work with the Obama White House as former head of the Environmental Protection Agency (EPA).

Discovery also welcomes Marc Goodman, New York Times best-selling author, founder of the Future Crimes Institute, and global strategist as a featured presenter on the panel Lessons in Innovation from the Criminal Underground and the Future of Financial Crimes.

OCE is also excited to feature panels with some of Canada's leading entrepreneurs at Discovery 2017 including;

  • Technology of the Future
  • Seizing Opportunity in China
  • Future of Ontario's Health System: Driving Value and Impact
  • Next-Generation Transportation
  • Scale-Ups: How Ontario Entrepreneurs are Scaling Up and Attracting International Attention

A networking bonanza, Discovery provides students, job seekers, young entrepreneurs and start-ups seeking investment and an array of opportunities to interact with experts, investors, potential collaborators and employers.

This includes:

Meet An Investor, where attendees can meet one-on-one with expert investors, entrepreneurs, innovation agents, and professional services and export specialists.

Discovery's Book a Meeting feature, which attendees can use to message and book timeslots to meet before, during or after Discovery with other attendees, exhibitors, and investors on the show floor.

The B2B and B2G Zones. In keeping with the aim of making Discovery a place to do business, the conference will also facilitate meetings between large corporations and start-ups and scale-ups through its B2B Zone, and meetings between businesses and government through the new B2G Zone.

Discovery will also highlight:

Ontario-based companies showcasing their accessibility-focused innovations in the Accessibility Innovation Showcase on the Discovery show floor in partnership with Ontario's Ministry of Economic Development and Growth.

Ontario-based companies exhibiting social innovations in the Social Enterprise Zone.

Now a crowd-pleasing favourite, Discovery 2017 will also hold four pitch competitions featuring some of Ontario's brightest entrepreneurs from across the province:

  • Young Entrepreneurs, Make Your Pitch for high-school students
  • Accessibility Innovation Tech Pitch Competition
  • Social Enterprise Pitch Competition
  • ONtrepreneurs Pitch Challenge presented by the Ontario Brain Institute

Discovery continues to promote the exchange of ideas and encourage new ways to collaborate and push the boundaries of research and innovation through to demonstration and development. With so many thought leaders in one place, attending Discovery is a great way to explore Ontario's bright future in the global innovation ecosystem.

For more on Discovery, visit www.ocediscovery.com

Richard Crenian joins 12th Annual Scotiabank Pro Am Alzheimer's Tournament in support of Baycrest

 

TORONTO, May 10, 2017 /CNW/ - This past weekend, Richard Crenian, president of ReDev Properties Ltd. participated in the 12th Annual Scotiabank Pro-Am Hockey tournament for Alzheimer's in support of Baycrest. The tournament is held in May each year and Crenian has regularly attended for the past decade. Participating teams drafted and were joined by 27 NHL Alumni players including Paul Coffey, Wendel Clark and Lanny McDonald.

The tournament raised over $1.5 million for Baycrest Health Sciences this year. Coming in as the runner up for the most funds raised individually, Richard Crenian fundraised over $59,000 to support the cause. The team he played with, The Coop Architects were also runners up for most funds raised as a team with over $113,000 donated.

"I'm a big fan of hockey," says Richard Crenian. "But I'm also passionate about using a sport to bring the community together to support an important cause, such as funding for Alzheimer's research. That's a big reason why I continuously support this tournament."

Aside from partaking in the annual hockey tournament, Crenian decided in 2015 to increase his dedication to the charity and established a Match My Gift Campaign to further support Baycrest in Alzheimer's care and research. With the Match My Gift Campaign, every dollar a generous donor gives, Baycrest will receive double the donation through Crenian's support.

"The more I learned about Baycrest, the more impressed I became with the organization and the donor community," says Crenian. "I wanted to honour these donors by matching their generosity, and increasing our impact for the cause together."

Crenian's Match My Gift Campaign will again take place in fall 2017. Accept Richard's challenge this year and double your generous impact. For more information about the campaign please visit here.

About ReDev Properties

ReDev Properties Ltd. is a Canadian commercial real estate asset manager. Since 2001, the company has purchased and managed over 30 commercial real estate properties in Canada. ReDev Properties locates existing commercial real estate properties in markets that will ensure assets retain, and increase, in value for necessary stability and future growth. The company's founder and President, Richard Crenian has managed over two billion dollars in real estate assets since 1981.

For more information please visit:
http://www.redevgroup.com/

About Match My Gift Campaign

Richard Crenian has created a $100,000 Matching Gift Fund to support the Annual Campaign for Baycrest. Crenian will match your donation dollar for dollar. Gifts by you and other donors will have double the impact.

For more information please visit:
http://www.baycrest.org/give/ways-to-give/match-my-gift/

SOURCE ReDev Properties Ltd

New gluten-free food standards produced for the food service, hospitality sector now available to Celiac and gluten-free community

 

MISSISSAUGA, ON, May 8, 2017 /CNW/ - The Canadian Celiac Association, Fondation québécoise de la maladie coeliaque, and Gluten-Free Food Program Inc. have joined forces to create and promote the new industry standard for the celiac community.

The Gluten-Free Food Program Inc. (GFFPI) is pleased to announce the launch of its GF-Smart, GF-Verified and GF-Dedicated programs for the food service and hospitality industry. The Gluten Free Food Program (GFFP) has been developed with the endorsements from the Canadian Celiac Association (CCA) and Québec-based Fondation québécoise de la maladie coeliaque (FQMC); Canada's two authoritative voices for those living gluten-free. This program will serve to improve the dining-out options for those suffering from a gluten-related medical disorder, by arming the food service and hospitality sector with standardized professional training, management systems and best practices.

Over 2.5 million Canadians are affected by gluten and need a consistent hospitality sector standard. Operators serving food on a commercial basis may choose or be required to provide a gluten-free menu option. The GFFPI has developed professional standards to serve the gluten-free population, including restaurants, caterers, camps, hotels, convention centers, healthcare and educational institutions, cafés, and fast food outlets.

"Gluten-free diners are looking for dining options that are safe," says Anne Wraggett, CCA President. "They often fear eating out due to negative past experiences and lack of consistency throughout the hospitality sector, increasing the risks of consuming gluten accidentally. Our members will be excited to visit and support these outlets."

Although the term gluten-free is widely used in the food service and hospitality sector, it is often misunderstood, unpredictably executed, and thus an unreliable assurance of a safe dining experience. Until now, a national training standard that the industry in Canada could turn to has not been available.  Now, and as part of their professional advancement, food handlers can learn about the importance of proper food handling and avoid accidental contamination of gluten-free food. For food service and hospitality operators, GF-Smart functions as a strategic business partner by standardizing food handler training, thereby improving customer service, fostering staff engagement and reducing the risk of negative publicity for those establishments who employ GF-Smart trained staff.

The Canadian Society for Nutrition Management (CSNM), the national association representing Food and Nutrition Managers across Canada, has adopted GF-Smart as part of their member curriculum. Dave Lebert, CSNM Continuing Education Chair, says "Gluten-free diets, procurement of safe food for these special diets, and, most critical, the teaching and providing direction to our staff who work with gluten-free clients, are among the many facets of responsibilities of which our members endure on a daily basis. We are thrilled to partner with GFFP to offer the GF-Smart program to our members, and even more excited to include this course as part of CSNM's Continuing Education program, worth one Continuing Education (CE) credit for our members."

GF-Verified and GF-Dedicated standards have been created to ensure a consistent approach to internal management systems. From the purchase of ingredients, food storage, preparation, cooking, service, and delivery of gluten-free meals, GF-Verified denotes an establishment that provides both regular and gluten-free meals. GF-Dedicated indicates that all meals provided within the establishment are gluten free.

Our logos for the GF-Verified and GF-Dedicated programs will be displayed to indicate to the gluten-free community that an establishment has achieved the GFFP standards and in doing so has been externally audited by an independent auditor.

About Gluten-Free Food Program (GFFP): The Gluten-Free Food Program Inc. is a privately held corporation which owns and operates the GF-Smart and GF-Verified and GF-Dedicated programs, developed and managed with the endorsement of the Canadian Celiac Association and Québec-based Fondation québécoise de la maladie coeliaque, Canada's two authoritative voices for those living gluten-free. http://www.glutenfreefoodprogram.com

About Canadian Celiac Association (CCA): The Canadian Celiac Association is the national voice for people who are adversely affected by gluten, and is dedicated to improving diagnosis and quality of life. Based in Mississauga, Ontario, with chapters across the country, its mission includes advocacy, education, research and community support. http://www.celiac.ca

About Fondation québécoise de la maladie coeliaque (FQMC): The Fondation québécoise de la maladie coelique provides services and support to its members in the French language. Its mission is to improve the lives of people who are affected by celiac disease or non-celiac gluten sensitivity with information on the disease and the gluten-free diet.http://www.fqmc.org

SOURCE Gluten Free Food Program Inc

Billion-dollar Growth Opportunities in Cancer Testing Market: How Will Collaborative Partnerships Drive Better Health Outcomes?

Cancer is the second major cause of death in the United States (U.S.). Every year, cancer claims the lives of more than half a million Americans. Frost & Sullivan has been researching how new technology advancement in next generation sequencing (NGS), proteomics and liquid biopsy will fuel growth in cancer screening, prognosis and therapy monitoring markets.

Our research on U.S. Oncology Diagnostics Market explores the growth opportunities; challenges in molecular and non-molecular technology segments across five different cancers namely breast cancer, ovarian cancer, cervical cancer, colorectal cancer, prostate cancer and lung cancer. The 2016 U.S. cancer diagnostics market is valued at $1.1 billion out of a market potential of $21.6 billion. If the full market potential is exploited, the annual revenue could grow to $25 billion by 2021.

ThinkstockPhotos-506606616

Clinicians have endorsed that screening at early detection, and therapy selection and monitoring are the short term promising applications of liquid biopsies, a non-invasive way of measuring biomarkers that can eliminate the need for biopsies where often the go-to site is a big concern. “Several diagnostic companies are expanding their product portfolio to include liquid biopsy and companion diagnostics in their long term strategy, Prominent pharmaceutical companies such as Merck, Bristol-Myers Squibb and Johnson & Johnson’s and their respective venture capital arm are investing heavily in liquid biopsy start ups," explains Transformational Health Principal Analyst Divyaa Ravishankar.As a result, convergence and collaboration between pharmaceutical and diagnostic companies are meant to grow significantly. With private insurance payers now covering the cost for new cancer assays that have a demonstrable economic advantage to the health continuum; the insurance market segment will continue to move to the value based reimbursement model. For this reason, many novel assays have proven to deliver cost-effective solutions to improve patient outcomes at a better healthcare economic cost. “Marketing strategies for companies such as 23andme and Provista Diagnostics receive a particular mention because they are advertising directly to consumers who in turn ask physicians to get tested with a particular company. This puts the patient as a key decision maker in the cancer care ecosystem,” adds Ravishankar. 

In addition, genomics technologies are increasingly being used to understand genetic changes associated with cancer progression. The trend is supported by increasing focus on preventive and personalized healthcare approaches from healthcare providers and payers. Further, lowering cost of genome sequencing and advancements in clinical interpretation capabilities of NGS data have supported the rise of this trend. “While a number of NGS informatics companies have already made significant investments to develop focused capabilities for NGS-based oncology diagnostics assays and therapies, there are still ample opportunities in this market, especially in the clinical interpretation and reporting segment,” concludes Piyush Bansal, Transformational Health Senior Industry Analyst.

The current U.S. NGS informatics market in genomic testing companies segment is expected to grow at a Compound Annual Growth Rate (CAGR) of 18% during 2016-2021. Subject to some positive regulatory and technology developments, the molecular diagnostics customer segment can offer more than $150 million in revenue to the NGS informatics industry, out of which a significant part of the revenue will be contributed by oncology diagnostics tests and assays. Also, the analysis predicts a strong growth of NGS informatics solutions in pharmaceutical and biopharmaceutical customer segment, as biopharma companies will look to increase their spend on disease research using NGS.

“Exercise-in-a-pill” boosts athletic endurance by 70 percent
Sedentary mice given the drug ran longer without training
LA JOLLA–Every week, there seems to be another story about the health benefits of running. That’s great–but what if you can’t run? For the elderly, obese or otherwise mobility-limited, the rewards of aerobic exercise have long been out of reach.

Salk Institute scientists, building on earlier work that identified a gene pathway triggered by running, have discovered how to fully activate that pathway in sedentary mice with a chemical compound, mimicking the beneficial effects of exercise, including increased fat burning and stamina. The study, which appears this week in Cell Metabolism, not only deepens our understanding of aerobic endurance, but also offers people with heart conditions, pulmonary disease, type 2 diabetes or other health limitations the hope of achieving its benefits pharmacologically.

“It’s well known that people can improve their aerobic endurance through training,” says senior author Ronald Evans, Howard Hughes Medical Institute investigator and holder of Salk’s March of Dimes Chair in Molecular and Developmental Biology. “The question for us was: how does endurance work? And if we really understand the science, can we replace training with a drug?”

Developing endurance means being able to sustain an aerobic activity for longer periods of time. As people become more fit, their muscles shift from burning carbohydrates (glucose) to burning fat. So researchers assumed that endurance is a function of the body’s increasing ability to burn fat, though details of the process have been murky. Previous work by the Evans lab into a gene called PPAR delta (PPARD) offered intriguing clues: mice genetically engineered to have permanently activated PPARD became long-distance runners who were resistant to weight gain and highly responsive to insulin–all qualities associated with physical fitness. The team found that a chemical compound called GW1516 (GW) similarly activated PPARD, replicating the weight control and insulin responsiveness in normal mice that had been seen in the engineered ones. However, GW did not affect endurance (how long the mice could run) unless coupled with daily exercise, which defeated the purpose of using it to replace exercise.

In the current study, the Salk team gave normal mice a higher dose of GW, for a longer period of time (8 weeks instead of 4). Both the mice that received the compound and mice that did not were typically sedentary, but all were subjected to treadmill tests to see how long they could run until exhausted.

Mice in the control group could run about 160 minutes before exhaustion. Mice on the drug, however, could run about 270 minutes–about 70 percent longer. For both groups, exhaustion set in when blood sugar (glucose) dropped to around 70 mg/dl, suggesting that low glucose levels (hypoglycemia) are responsible for fatigue.

To understand what was happening at the molecular level, the team compared gene expression in a major muscle of mice. They found 975 genes whose expression changed in response to the drug, either becoming suppressed or increased. Genes whose expression increased were ones that regulate breaking down and burning fat. Surprisingly, genes that were suppressed were related to breaking down carbohydrates for energy. This means that the PPARD pathway prevents sugar from being an energy source in muscle during exercise, possibly to preserve sugar for the brain. Activating fat-burning takes longer than burning sugar, which is why the body generally uses glucose unless it has a compelling reason not to–like maintaining brain function during periods of high energy expenditure. Although muscles can burn either sugar or fat, the brain prefers sugar, which explains why runners who “hit the wall” experience both physical and mental fatigue when they use up their supply of glucose.

“This study suggests that burning fat is less a driver of endurance than a compensatory mechanism to conserve glucose,” says Michael Downes, a Salk senior scientist and co—senior author of the paper. “PPARD is suppressing all the points that are involved in sugar metabolism in the muscle so glucose can be redirected to the brain, thereby preserving brain function.”

Interestingly, the muscles of mice that took the exercise drug did not exhibit the kinds of physiological changes that typically accompany aerobic fitness: additional mitochondria, more blood vessels and a shift toward the type of muscle fibers that burn fat rather than sugar. This shows that these changes are not exclusively driving aerobic endurance; it can also be accomplished by chemically activating a genetic pathway. In addition to having increased endurance, mice who were given the drug were also resistant to weight gain and more responsive to insulin than the mice who were not on the drug.

“Exercise activates PPARD, but we’re showing that you can do the same thing without mechanical training. It means you can improve endurance to the equivalent level as someone in training, without all of the physical effort,” says Weiwei Fan, a Salk research associate and the paper’s first author.

Although the lab’s studies have been in mice, pharmaceutical companies are interested in using the research to develop clinical trials for humans. The team can envision a number of therapeutic applications for a prescription drug based on GW, from increasing fat-burning in people suffering from obesity or type 2 diabetes to improving patients’ fitness before and after surgery.

Other authors included Wanda Waizenegger, Chun Shi Lin, Ming-Xiao He, Christopher E. Wall, Ruth T. Yu, Annette R. Atkins of Salk; Vincenzo Sorrentino, Hao Li and Johan Auwerx of the Ecole Polytechnique Federale de Lausanne; and Christopher Liddle of the University of Sydney.

The work was funded by the National Institutes of Health, the National Health and Medical Research Council of Australia, The Leona M. and Harry B. Helmsley Charitable Trust, the Samuel Waxman Cancer Research Foundation, Stand Up to Cancer and Ipsen Bioscience, Inc.

About the Salk Institute for Biological Studies:
Every cure has a starting point. The Salk Institute embodies Jonas Salk's mission to dare to make dreams into reality. Its internationally renowned and award-winning scientists explore the very foundations of life, seeking new understandings in neuroscience, genetics, immunology, plant biology and more. The Institute is an independent nonprofit organization and architectural landmark: small by choice, intimate by nature and fearless in the face of any challenge. Be it cancer or Alzheimer's, aging or diabetes, Salk is where cures begin.

Take on the city with adidas PureBOOST DPR, engineered to deliver a raw, real and adaptive street running experience

Signature BOOST technology with a new 8mm head-to-toe offset stores and unleashes energy more effectively
HERZOGENAURACH, GERMANY — Today adidas revealed its latest addition to the PureBOOST franchise that launched earlier this year. The new PureBOOST DPR is an  innovation engineered to take runners closer to the city streets. The shoe is made for those whose unafraid attitude makes no urban environment unconquerable. The new agile and adaptive design features the latest application of adidas’ industry leading BOOST technology, with a new 8mm heel-to-toe offset, that stores and unleashes energy more effectively every time it hits the ground, enabling runners to truly ‘feel’ the streets.

When developing PureBOOST DPR, adidas looked at the needs of the urban runner and designed a shoe that is as dynamic and adaptable as they are. PureBOOST DPR was created to support runners dodging traffic, racing street lights and weaving through pedestrians, working with the unpredictable surroundings and harnessing its energy.

“All over the world, runners are exploring cities and expressing their own creativity in the routes they choose and the challenges they take on." said Stephan Schneider, Product Manager at adidas Global Running. "We wanted to build something purely designed for this type of runner, and loved the idea of creating a more adaptive running experience. This led us to design an 8mm heel-to-offset, that when paired with signature BOOST technology allows the feet to sit lower, deeper, and much closer to the streets.”

The shoe’s key features include:

  • One-piece engineered circular knit upper - Aramis-tested for a seamless and adaptive fit, wrapping the foot from the inside of the midfoot around to the outside. Providing comfort no matter the route or obstacle.
  • Heel fit counter system - designed to enhance the support of the foot and the Achilles, while allowing the foot to move effortlessly with the shoe.
  • Wider forefoot - providing a more stable platform that tailors itself in the pivotal moments of transition when running over various urban surfaces and around corners.
  • Stretchweb outsole - enabling a smoother and more flexible ride, working in harmony with BOOST to unleash a runner’s full potential.
  • BOOST - ultra-responsive comfort and cushioning that stores and returns energy every time the foot hits the ground.

The adidas PureBOOST DPR will be available late May 2017 at adidas.ca/PureBOOST.

Twitter: @adidasca
Instagram: @adidasca
#PureBOOST

New National Mental Health Coalition Seeks Equitable Access to Depression Medications

'An employment lottery should not be the basis for treating the most significant public health issue of the 21st century'

OTTAWA, May 3, 2017 /CNW/ - During CMHA's Mental Health Week, Canadians are being asked to 'get loud' for mental health. It's all part of this year's Sick of Waiting: Get Loud for Mental Health campaign. A newly formed group of mental health professionals and leaders, advocates, doctors, academics and people with lived experience is lending its voice to the campaign — and calling for changes to Canada's public drug plan system that prevents many Canadians from getting the treatment they need to get better.

The Canadians for Equitable Access to Depression Medication (CEADM) coalition — led by three of Canada's strongest advocates for mental wellness, Phil Upshall, National Executive Director of the Mood Disorders Society of Canada; Dr. Patrick Smith, CEO of the Canadian Mental Health Association; and Jeff Moat, President of Partners for Mental Health — states that under the current system, Canada's most vulnerable — the marginalized, the unemployed, veterans, seniors, single parents, Indigenous peoples — are unable to access the latest medications that could help them get better.

In forming the coalition, CEADM intends to:

  • create awareness and recognition among policy-makers about the complexity of major depressive disorder and the effects of depression on Canadians' overall health;
  • highlight the inequity issue for many Canadians who rely on what is a broken public drug plan approval system; and
  • make better depression care a priority among policy-makers.

Improving the system will go a long way to treating what is the most significant public health issue of the 21st century.

"Canadians who live with mental illness already face the barrier of stigma as well as being debilitated by this disease," says Mr. Upshall. "But in Canada, people who rely on the provincial and territorial public drug plans either can't get access to or face considerable delays in accessing the latest medicines to treat their illness. Contrast this to people with private plans, where access to innovative medicines is far more efficient and timely."

Dr. Smith points out that this federal government has taken a bold leadership stand for mental health.  Federal Minister of Health Jane Philpott has remarked on the importance of improving accessibility to pharmaceuticals for Canadians and investing more into mental health treatment. Through her leadership and that of her fellow ministers, we are beginning to see real action taken to transform Canada's response to mental health. "Yet, despite open conversations and thoughtful discourse, despite public policy strategies and emerging philanthropic interest in mental health, people who are living with mental illness still struggle to get the care and supports they need, with ease and without prejudice," Dr. Smith adds.

Compared to other OECD countries, Canada can do better, says Laureen MacNeil, CEADM's Alberta Regional Co-Chair and Executive Director, CMHA Calgary Region: "Access to new medicines in Canada's public drug plans is lagging when compared to access in private sector drug plans, and when compared to public drug plans in other countries."

First responders like Ron Campbell, a retired RCMP officer from Alberta who has dealt with post-traumatic stress disorder and major depression, and is a member of the national coalition, appreciates the fact that his private drug plan enabled him to get the support and therapy he needed. "I'm one of the lucky ones whose private drug plan covered some of these innovative new medicines. But there are so many Canadians who aren't as fortunate as I. Access to the right medicines shouldn't be an issue for anyone. It isn't right."

The one in five Canadians who experience mental illness and the $51 billion-a-year-cost to the Canadian economy underscore the scale of the problem.

"Depression is a significant public health issue, and it's getting more problematic," says Ann Marie MacDonald, CEADM's Ontario Regional Co-Chair and Executive Director of the Mood Disorders Association of Ontario. "One in five Canadians is affected by mental illness and about 4,000 die by suicide every year. Sadly, suicide is a leading cause of death among our young people. Yet, despite the magnitude of the problem, government investment in mental health care is modest at best."

CEADM's call for change to the public drug plan system is both an equity issue and a moral issue.

"It is time for Canada to change the way we support people with mental health problems or illness.  Access to treatment should not be limited to those select few with employment benefits," adds Mr. Moat. "Changing the process that recommends drugs for reimbursement by provincial and territorial public drug plans to allow all Canadians access to the latest and best drugs to treat this complex illness is the right thing to do."

Backgrounder - Canadians for Equitable Access to Depression Medication (CEADM)

In an unprecedented move, mental health professionals and leaders, advocates, doctors, academics and people with lived experience from across the country have joined together to form a coalition to ensure equitable and sustainable access for all Canadians suffering with depression.

Through Canadians for Equitable Access to Depression Medication (CEADM), these coalition members are speaking with a common voice on behalf of Canadians who need equitable access to medication to treat their depression, regardless of their income, education or access to employment benefits.

CEADM's objectives are to:

  • create awareness among policy-makers about the complexity of major depressive disorder and the effects of depression on Canadians' overall health;
  • highlight the inequity/fairness issue for many Canadians who rely on a public drug plan approval system that requires fixing; and
  • make depression care a priority among policy-makers.

The Issue Around Inequity and the Public Drug Plan System

At the heart of the problem, preventing vulnerable Canadians from accessing the latest medicines, are three related issues.

Number 1: Depression is complex, with 227 different combinations of symptoms. There is no 'one-size-fits-all' approach to treatment. A wide choice of therapy is critical to be able to find the best option for individual patients when it comes to treating mental illness — one that addresses not only mood but also changes in sleep patterns and appetite, as well as cognition.

Number 2: Canadians who depend on public drug coverage because of a lack of income, education or access to employment benefits are limited to a range of drugs that are available to treat depression. Currently, public drug plans only cover medications that were developed to address mood symptoms However, as we learn and understand more about depression, it is clear that a broader range of choice of medications brings with it a greater probability of success. Unfortunately, that broader range of choice of medications is not available to those on public drug plans.

Number 3: Despite the fact that innovative medications have been approved as safe and effective treatments by Health Canada, a complex multi-stage review process is preventing these medications from being approved for public drug plan coverage.

Under the current system, new drugs are submitted to a health technology assessment (HTA) agency for evaluation. While it is not the only element that is evaluated, the cost of a medication does play a significant role in the decision-making process, even though HTA evaluations are meant to be evidence-based, where clinical effectiveness and safety are also considered. The Canadian Agency for Drugs and Technologies in Health (CADTH) then releases its final recommendations to the federal and provincial/territorial governments.

Of the 21 new mental health drug submissions filed to the CADTH between 2004 and 2015:

  • 76.2% were given negative recommendations for public drug plan coverage.
  • 100% of the submissions for major depressive disorder received a negative recommendation — not listed for reimbursement — while of the 134 non-mental health drug submissions, 65 (48.5%) received a negative recommendation.
  • The review process was considerably lengthier, at 242 days on average for mental health drugs compared to 192 days for non-mental health drugs.
  • It is estimated that the direct costs of new mental health drugs on provincial, territorial and the federal Non-Insured Health Benefits (NIHB) public drug plans represents less than 1 percent of the more than $54 billion in societal costs associated with the economic burden of mental illness in Canada.

Furthermore:

  • Public drug plan spending on the direct costs of new mental health drugs was less than 1% of the more than $54.6 billion associated with the total economic burden of mental illness in Canada for 205.

Members of Canadians for Equitable Access to Depression Medication to date:

Phil Upshall, National Leadership Team, Mood Disorders Society of Canada

Dr. Patrick Smith, National Leadership Team, Canadian Mental Health Association

Jeff Moat, National Leadership Team, Partners for Mental Health

Ann Marie MacDonald, Regional Ontario Co-Chair; Mood Disorders Association of Ontario

Michael Landsberg, Regional Ontario Co-Chair; #SickNotWeak

Laureen MacNeil, Regional Alberta Co-Chair; Canadian Mental Health Association, Calgary

Ron Campbell, Regional Alberta Co-Chair; person with lived experience

Dave Grauwiler, Canadian Mental Health Association, Alberta

Camille Quenneville, Canadian Mental Health Association, Ontario

Dr. Sid Kennedy, University Health Network

Pratap Chokka, Chokka Centre for Integrative Health

Bill Gaudette, formerly CMHA, Past Member, Provincial Mental Health Board (Alberta)

Brianne Moore, person with lived experience, Ontario

Jean-François Claude, person with lived experience, Ontario

SOURCE Coalition for Equitable Access to Depression Medication

canfitpro world fitness expo 2017 brings industry elite to Toronto including Tony Horton and Shawn T
Canada's largest fitness event returns to the Metro Toronto Convention CentreAugust 16-20 with over 300 leading-edge fitness education sessions and 200 international experts
TORONTO, ON — canfitpro, Canada’s largest provider of fitness education, brings its world fitness expo back to Toronto from August 16 to 20, at the Metro Toronto Convention Centre. As the largest fitness conference and trade show in the world, canfitpro draws in over 16,000 delegates and visitors each year. In its 24th annual run, this internationally-recognized event will continue to inspire a certified healthy and active lifestyle across the country.
World-renowned fitness expert, Tony Horton (creator of P90X), will kick off Thursday’s opening ceremonies with an inspirational discussion about his personal journey, tips for maximizing motivation and how to live a more productive lifestyle.

During the five-day event, attendees will have the opportunity to customize their experience with a selection of over 300 sessions presented by over 200 international experts. From heart-pumpingworkouts to stimulating lectures from the greatest minds in the industry, attendees will find inspiration and education in the many fields of wellness where their passions align.

Attendees will enjoy a variety of activities, contests, exclusive shopping experiences at the show’s Expo Hall, featuring hundreds of companies providing amazing deals on the latest products and services, as well as sessions led by some of the world’s top fitness celebrities such as:
  • Shaun T – Creator of INSANITY, CIZE and HipHop Abs
  • Tosca Reno – Bestselling Author, ‘Eat Clean Queen’
  • Kathy Smart – Gluten Free Expert
  • Joel Freeman, Jericho McMatthews, Nichelle Laus – Beachbody Super Trainers
  • Tommy Europe – SHRED BOOTCAMP fitness coach
“canfitpro’s purpose is to inspire healthy living through fitness education,” says Rod Macdonald, Vice President of canfitpro.world fitness expo is the only place where you will find as much education at the lowest price for an event of this kind.”

CEO of GoodLife Fitness, David Patchell-Evans, will close the weekend with a powerful presentation on his personal challenges and experiences, and the role gratitude plays in living a happy, healthy and successful life.

With a mission to make Canada healthier and stronger, world fitness expo is a riveting, educational and life-changing experience.

Event registration is currently available at early bird pricing under the following categories: non-members (general public), canfitpro members, and student members. Attendees can customize their experiences based on what day(s) they would like to attend, and the different intensives they would like to participate in.

For those looking to attend Expo Hall only, tickets can be purchased for $20 (inclusive of tax), beginning on Friday, May 5.

The event brochure, including a full cost breakdown, list of additional keynote speakers and a complete session schedule can be viewed here.

Website: www.worldfitnessexpo.com
Twitter: @canfitpro
Instagram: @canfitpro
Facebook: @canfitpro
Hashtag: #canfitpro #worldfitnessexpo

About canfitpro
canfitpro is the largest provider of education in the Canadian fitness industry. Founded in 1993, canfitpro delivers accessible, quality education, certifications, events and membership services. canfitpro's over 100,000 members include some of the world's finest fitness professionals, health club operators, industry suppliers, and fitness consumers.

Using Reality TV to Improve Men's Mental Health

Toronto psychiatrist creates bold, experimental web series Think You Can Shrink? to improve men's mental health and reduce stigma.

TORONTO, May 1, 2017 /CNW/ - A Toronto psychiatrist has developed a unique initiative to help remove the stigma associated with mental health issues among men and encourage them to seek professional help.

Dr. Thomas Ungar, an Associate Professor at the University of Toronto and Head of Psychiatry at North York General Hospital, created Think You can Shrink?, a reality TV-style web series that is generating positive results among viewers.

"Mental health issues are widely misunderstood and stigmatized among the general public," Dr. Ungar said. "I wanted to create something that goes beyond traditional health promotion. I hope that by playing with everyday pop culture like a reality show, we can help people become more comfortable with mental illness and get the help they need."

With innovation funding from the Movember Foundation, the world's leading men's health charity, and support from the North York General Hospital Foundation, Dr. Ungar created Think You Can Shrink?, a three-episode web series that focuses on intimate subjects rarely portrayed in popular culture: suicidal depression, testicular lumps, and explaining how to deal with a narcissist.

"Mental health issues are particularly acute among men, who are more likely than women to try to tough it out or struggle alone," Dr. Ungar said, noting that three out of four suicides are men and that suicide is the second-leading cause of death among men aged 15 to 29.

Employing a method used to train medical students, actors are coached to portray mental health problems.  Contestants with everyday jobs who think they are good at giving advice (a bartender, a hairdresser and a strip club owner) test their skills – both successfully and unsuccessfully.  Judges include a psychiatrist, an emergency room/family doctor and celebrity Rick Campanelli, co-host of ET Canada.

"It was a fine line to walk, trying to not be exploitive of mental health issues, but entertaining so people would watch" Dr. Ungar said.  The web series avoids the shaming factor of reality TV to show that strong male support and communication is possible, de-stigmatizing the act of reaching out for help.

A survey of people who watched the episodes concludes that the reality TV-style was successful in de-stigmatizing mental health issues and encouraging people to seek professional care.  Seventy-five per cent of viewers said they were more likely to seek help if needed, and 86% would be more comfortable supporting a friend or family member who had the same health issue as portrayed in the video, according to the study in the Journal of Technology and Behavioral Science.

About the Movember Foundation:

The Movember Foundation is the only global charity focused solely on men's health. We raise funds that deliver innovative, breakthrough research and support programs to enable men to live happier, healthier, longer lives. Awareness and fundraising activities are run year-round, with the annual Movember Campaign in November being globally recognized for its fun, disruptive approach to fundraising and getting men to take action for their health. Since Movember started in Melbourne, Australia in 2003, millions have joined the movement, raising over $759 Million and funding over 1,200 projects focused on men's mental health & suicide prevention, prostate and testicular cancer. You can help stop men dying too young at movember.com.

SOURCE Dr. Tom Ungar